Jun 9, 2020Paper

An OpenData portal to share COVID-19 drug repurposing data in real time

BioRxiv : the Preprint Server for Biology
K. R. BrimacombeMin Shen

Abstract

The National Center for Advancing Translational Sciences (NCATS) has developed an online open science data portal for its COVID-19 drug repurposing campaign, named OpenData, with the goal of making data across a range of SARS-CoV-2 related assays available in real-time. The assays developed cover a wide spectrum of the SARS-CoV-2 life cycle, including both viral and human (host) targets. In total, over 10,000 compounds are being tested in full concentration-response ranges from across multiple annotated small molecule libraries, including approved drug, repurposing candidates and experimental therapeutics designed to modulate a wide range of cellular targets. The goal is to support research scientists, clinical investigators and public health officials through open data sharing and analysis tools to expedite the development of SARS-CoV-2 interventions, and to prioritize promising compounds and repurposed drugs for further development in treating COVID-19.

Citations

Sep 24, 2020·Journal of Biomolecular Structure & Dynamics·Shubhangi Kandwal, Darren Fayne
Nov 6, 2020·Nucleic Acids Research·Sorin AvramTudor I Oprea
Nov 10, 2020·Nucleic Acids Research·Dmitry TworowskiMilana Frenkel-Morgenstern
Jan 14, 2021·The Biochemical Journal·George M Burslem
Feb 6, 2021·Expert Opinion on Drug Discovery·Ziaurrehman TanoliTero Aittokallio
Mar 4, 2021·Journal of Cheminformatics·Rajarshi GuhaNina Jeliazkova
Mar 13, 2021·Frontiers in Pharmacology·Catherine Z ChenWei Zheng
Apr 22, 2021·Advances and Applications in Bioinformatics and Chemistry : AABC·Bruno O VilloutreixPhilippe Beaune
Dec 22, 2020·ACS Infectious Diseases·Kirill GorshkovWei Zheng
Jul 3, 2021·Chemical Society Reviews·Eugene N MuratovAlexander Tropsha
Jul 28, 2021·Journal of Chemical Information and Modeling·Hazem MslatiArtem Cherkasov
Dec 18, 2020·ACS Pharmacology & Translational Science·Giovanni BocciTudor I Oprea
Oct 17, 2020·ACS Pharmacology & Translational Science·Jonathan H ShrimpMatthew D Hall
Oct 17, 2020·ACS Pharmacology & Translational Science·Wei ZhuWei Zheng
Sep 17, 2021·Proceedings of the National Academy of Sciences of the United States of America·Wengong JinRegina Barzilay
Oct 6, 2021·ACS Pharmacology & Translational Science·Sankalp JainAlexey V Zakharov
Nov 24, 2021·Journal of Medicinal Chemistry·Henry R O'DonnellBrian K Shoichet
Dec 6, 2021·Briefings in Bioinformatics·Nicoleta SimineaIon Petre
Jan 22, 2022·Journal of Chemical Information and Modeling·Gergely Zahoránszky-KőhalmiTudor I Oprea
Feb 3, 2022·Journal of Chemical Information and Modeling·Debarati DasGuptaHeather A Carlson

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

BioRxiv : the Preprint Server for Biology
K. R. BrimacombeMin Shen
Expert Opinion on Therapeutic Patents
Ilaria VicentiFrancesco Saladini
Memórias do Instituto Oswaldo Cruz
Mario Roberto SengerFloriano Paes Silva-Junior
© 2022 Meta ULC. All rights reserved